Pinealon (20mg)

Pinealon (20mg): Product Description

Pinealon is a synthetic regulatory tripeptide commonly represented by the sequence glutamic acid–aspartic acid–arginine, abbreviated as Glu‑Asp‑Arg or EDR. It is supplied as a research material for controlled investigation of short-chain peptide activity in neuronal and cellular systems.

Laboratory models involving Pinealon may examine gene-expression regulation, oxidative-stress responses, neuronal signaling and molecular pathways associated with cellular aging. Researchers may also study the relationship between its three-residue structure and cellular uptake, peptide stability and sequence-dependent signaling.

This 20 mg presentation contains the same peptide identity as the 10 mg format. The larger quantity does not change the molecular formula, molecular weight or amino-acid sequence. However, counterions, salt forms and terminal modifications may affect analytical mass and should be confirmed using the batch-specific Certificate of Analysis.

Because published commercial descriptions of Pinealon are not always consistent, Molecular Edge should avoid identifying it as a four-amino-acid peptide unless its own COA documents an additional residue. The specifications below correspond to the commonly cited EDR tripeptide.

Research Specifications

Molecular Formula: Approximately C15H26N6O8

Molecular Weight: Approximately 418.41 g/mol

Amino Acid Count: 3

Sequence: Glu-Asp-Arg

Compound Type: Synthetic short regulatory peptide

Presentation: 20 mg

Research Areas: Neuronal and cellular-signaling models

Required Verification: Product-specific COA

For Research Use Only. Not for human or animal consumption. Not intended for diagnostic or therapeutic use.